I haven't looked at anything in detail but emails are screen captures (PNG files).
The main zip contains password protected 7z files and the password (the main zip is just a container which doesn't have a password itself). I would recommend exploring using a VM only but seems legit from what I can tell. You'll need 7zip to extract because it uses AES encryption.
- EMA LEAKS.7z
- Leaked Files from EMA.7z
- password.txt
Exploded contents for the above:
- /tmp/leaks/Priority OCs in quality LoQ - COVID-19 mRNA Vaccine BioNTech.docx
- /tmp/leaks/EudraLink - H0005735_ Transfer Plan 11.11.2020
- /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - CHMP Opinion.docx
- /tmp/leaks/11.PNG
- /tmp/leaks/09. Applicant-Rapps-EMA CMC TC - 26.11.2020
- /tmp/leaks/12.PNG
- /tmp/leaks/Rapporteur's Rolling Review Report New Active Substance Status - COVID-19 mRNA Vaccine BioNTec.doc
- /tmp/leaks/01.png
- /tmp/leaks/Written procedure for COVID-19_mRNA_Vaccine_BioNTech-5735 – for your comments by 30_11 17_00 CET.msg
- /tmp/leaks/07.PNG
- /tmp/leaks/p3.jpg
- /tmp/leaks/03.PNG
- /tmp/leaks/Rapporteur Rolling Review Report Overview LoQ - COVID-19 mRNA Vaccine BioNTech.docx
- /tmp/leaks/Agenda for ETF meeting on COVID-19 vaccines - 26 November 2020.docx
- /tmp/leaks/10.PNG
- /tmp/leaks/08.PNG
- /tmp/leaks/MLT rolling report on COVID-19 discussions.docx
- /tmp/leaks/Eudralink to company - 30.11.2020
- /tmp/leaks/2020 11 20 ARs to applicant
- /tmp/leaks/2_1.png
- /tmp/leaks/M3 20 Nov 2020 FDA Query Responses.pdf
- /tmp/leaks/Rapporteur's Rolling Review Report Quality - COVID-19 mRNA Vaccine BioNTec.doc
- /tmp/leaks/INX100434736_AnalyticalMethodTransferBNT162b2-DPMethods.pdf
- /tmp/leaks/04.PNG
- /tmp/leaks/Annex 3 - BNT162b2 Manufacturing Equipment and Scale.pdf
- /tmp/leaks/p2.jpg
- /tmp/leaks/3.png
- /tmp/leaks/BNT162b2 EMA-Rapp CMC Meeting 26-Nov-2020
- /tmp/leaks/06.PNG
- /tmp/leaks/1_3.png
- /tmp/leaks/02. Rapporteur's (SE) AR
- /tmp/leaks/09.PNG
- /tmp/leaks/2.png
- /tmp/leaks/02.PNG
- /tmp/leaks/Peer Reviewers Comments_NO 23.11.2020.docx
- /tmp/leaks/1_1.png
- /tmp/leaks/p1.jpg
- /tmp/leaks/Annex 1 - Draft 3.2.P.2.2 Drug Product.pdf
- /tmp/leaks/post-meeting note priority of OCs
- /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - EMA peer review comments.docx
- /tmp/leaks/2020-11-26 ETF (vaccines)
- /tmp/leaks/M1 20 Nov 2020 FDA Query Responses.pdf
- /tmp/leaks/COVID-ETF recommendation on the start of rolling review for Ad26 COV2 S revSR
- /tmp/leaks/10. Interim Opinion - 30.11.2020
- /tmp/leaks/p4.jpg
- /tmp/leaks/Annex 4 - BNT162b2 CMC Data Timelines_for Pre-sub Meeting_PPQ.pdf
- /tmp/leaks/BNT CMC Peer Reviewer Comparability.pptx
- /tmp/leaks/20201126_BNT162b2_EMAmeeting_final.pptx
- /tmp/leaks/14.PNG
- /tmp/leaks/BWP report BioNTech mRNA COVID19 vaccine- Adopted.docx
- /tmp/leaks/05.PNG
- /tmp/leaks/2_2.png
- /tmp/leaks/1.png
- /tmp/leaks/06. Comments (Peer Review)
- /tmp/leaks/Annex 2 - VAL100130986 + attachment_All approved.pdf
- /tmp/leaks/2020 11 30 - Priority OCs to company.pdf
- /tmp/leaks/13.PNG
- /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - CHMP Overview and LoQ.docx
- /tmp/leaks/COVID-19 vaccine (recombinant, adjuvanted) Draft joint report as agreed by Rapps.docx
- /tmp/leaks/1_2.png
- /tmp/leaks/Summary of the ETF meeting on COVID-19 vaccine - 26 November 2020.docx
I haven't looked at anything in detail but emails are screen captures (PNG files).
The main zip contains 7z files and the password. I would recommend exploring using a VM only but seems legit from what I can tell. You'll need 7zip to extract because it uses AES encryption.
- EMA LEAKS.7z
- Leaked Files from EMA.7z
- password.txt
Exploded contents for the above:
- /tmp/leaks/Priority OCs in quality LoQ - COVID-19 mRNA Vaccine BioNTech.docx
- /tmp/leaks/EudraLink - H0005735_ Transfer Plan 11.11.2020
- /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - CHMP Opinion.docx
- /tmp/leaks/11.PNG
- /tmp/leaks/09. Applicant-Rapps-EMA CMC TC - 26.11.2020
- /tmp/leaks/12.PNG
- /tmp/leaks/Rapporteur's Rolling Review Report New Active Substance Status - COVID-19 mRNA Vaccine BioNTec.doc
- /tmp/leaks/01.png
- /tmp/leaks/Written procedure for COVID-19_mRNA_Vaccine_BioNTech-5735 – for your comments by 30_11 17_00 CET.msg
- /tmp/leaks/07.PNG
- /tmp/leaks/p3.jpg
- /tmp/leaks/03.PNG
- /tmp/leaks/Rapporteur Rolling Review Report Overview LoQ - COVID-19 mRNA Vaccine BioNTech.docx
- /tmp/leaks/Agenda for ETF meeting on COVID-19 vaccines - 26 November 2020.docx
- /tmp/leaks/10.PNG
- /tmp/leaks/08.PNG
- /tmp/leaks/MLT rolling report on COVID-19 discussions.docx
- /tmp/leaks/Eudralink to company - 30.11.2020
- /tmp/leaks/2020 11 20 ARs to applicant
- /tmp/leaks/2_1.png
- /tmp/leaks/M3 20 Nov 2020 FDA Query Responses.pdf
- /tmp/leaks/Rapporteur's Rolling Review Report Quality - COVID-19 mRNA Vaccine BioNTec.doc
- /tmp/leaks/INX100434736_AnalyticalMethodTransferBNT162b2-DPMethods.pdf
- /tmp/leaks/04.PNG
- /tmp/leaks/Annex 3 - BNT162b2 Manufacturing Equipment and Scale.pdf
- /tmp/leaks/p2.jpg
- /tmp/leaks/3.png
- /tmp/leaks/BNT162b2 EMA-Rapp CMC Meeting 26-Nov-2020
- /tmp/leaks/06.PNG
- /tmp/leaks/1_3.png
- /tmp/leaks/02. Rapporteur's (SE) AR
- /tmp/leaks/09.PNG
- /tmp/leaks/2.png
- /tmp/leaks/02.PNG
- /tmp/leaks/Peer Reviewers Comments_NO 23.11.2020.docx
- /tmp/leaks/1_1.png
- /tmp/leaks/p1.jpg
- /tmp/leaks/Annex 1 - Draft 3.2.P.2.2 Drug Product.pdf
- /tmp/leaks/post-meeting note priority of OCs
- /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - EMA peer review comments.docx
- /tmp/leaks/2020-11-26 ETF (vaccines)
- /tmp/leaks/M1 20 Nov 2020 FDA Query Responses.pdf
- /tmp/leaks/COVID-ETF recommendation on the start of rolling review for Ad26 COV2 S revSR
- /tmp/leaks/10. Interim Opinion - 30.11.2020
- /tmp/leaks/p4.jpg
- /tmp/leaks/Annex 4 - BNT162b2 CMC Data Timelines_for Pre-sub Meeting_PPQ.pdf
- /tmp/leaks/BNT CMC Peer Reviewer Comparability.pptx
- /tmp/leaks/20201126_BNT162b2_EMAmeeting_final.pptx
- /tmp/leaks/14.PNG
- /tmp/leaks/BWP report BioNTech mRNA COVID19 vaccine- Adopted.docx
- /tmp/leaks/05.PNG
- /tmp/leaks/2_2.png
- /tmp/leaks/1.png
- /tmp/leaks/06. Comments (Peer Review)
- /tmp/leaks/Annex 2 - VAL100130986 + attachment_All approved.pdf
- /tmp/leaks/2020 11 30 - Priority OCs to company.pdf
- /tmp/leaks/13.PNG
- /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - CHMP Overview and LoQ.docx
- /tmp/leaks/COVID-19 vaccine (recombinant, adjuvanted) Draft joint report as agreed by Rapps.docx
- /tmp/leaks/1_2.png
- /tmp/leaks/Summary of the ETF meeting on COVID-19 vaccine - 26 November 2020.docx
I haven't looked at anything in detail but emails are screen captures (PNG files).
The main zip contains 7z files and the password. I would recommend exploring using a VM only but seems legit from what I can tell. You'll need 7zip to extract because it uses AES encryption.
/tmp/leaks/EMA LEAKS.7z /tmp/leaks/Leaked Files from EMA.7z /tmp/leaks/password.txt
Exploded contents for the above:
/tmp/leaks/Priority OCs in quality LoQ - COVID-19 mRNA Vaccine BioNTech.docx /tmp/leaks/EudraLink - H0005735_ Transfer Plan 11.11.2020 /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - CHMP Opinion.docx /tmp/leaks/11.PNG /tmp/leaks/09. Applicant-Rapps-EMA CMC TC - 26.11.2020 /tmp/leaks/12.PNG /tmp/leaks/Rapporteur's Rolling Review Report New Active Substance Status - COVID-19 mRNA Vaccine BioNTec.doc /tmp/leaks/01.png /tmp/leaks/Written procedure for COVID-19_mRNA_Vaccine_BioNTech-5735 – for your comments by 30_11 17_00 CET.msg /tmp/leaks/07.PNG /tmp/leaks/p3.jpg /tmp/leaks/03.PNG /tmp/leaks/Rapporteur Rolling Review Report Overview LoQ - COVID-19 mRNA Vaccine BioNTech.docx /tmp/leaks/Agenda for ETF meeting on COVID-19 vaccines - 26 November 2020.docx /tmp/leaks/10.PNG /tmp/leaks/08.PNG /tmp/leaks/MLT rolling report on COVID-19 discussions.docx /tmp/leaks/Eudralink to company - 30.11.2020 /tmp/leaks/2020 11 20 ARs to applicant /tmp/leaks/2_1.png /tmp/leaks/M3 20 Nov 2020 FDA Query Responses.pdf /tmp/leaks/Rapporteur's Rolling Review Report Quality - COVID-19 mRNA Vaccine BioNTec.doc /tmp/leaks/INX100434736_AnalyticalMethodTransferBNT162b2-DPMethods.pdf /tmp/leaks/04.PNG /tmp/leaks/Annex 3 - BNT162b2 Manufacturing Equipment and Scale.pdf /tmp/leaks/p2.jpg /tmp/leaks/3.png /tmp/leaks/BNT162b2 EMA-Rapp CMC Meeting 26-Nov-2020 /tmp/leaks/06.PNG /tmp/leaks/1_3.png /tmp/leaks/02. Rapporteur's (SE) AR /tmp/leaks/09.PNG /tmp/leaks/2.png /tmp/leaks/02.PNG /tmp/leaks/Peer Reviewers Comments_NO 23.11.2020.docx /tmp/leaks/1_1.png /tmp/leaks/p1.jpg /tmp/leaks/Annex 1 - Draft 3.2.P.2.2 Drug Product.pdf /tmp/leaks/post-meeting note priority of OCs /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - EMA peer review comments.docx /tmp/leaks/2020-11-26 ETF (vaccines) /tmp/leaks/M1 20 Nov 2020 FDA Query Responses.pdf /tmp/leaks/COVID-ETF recommendation on the start of rolling review for Ad26 COV2 S revSR /tmp/leaks/10. Interim Opinion - 30.11.2020 /tmp/leaks/p4.jpg /tmp/leaks/Annex 4 - BNT162b2 CMC Data Timelines_for Pre-sub Meeting_PPQ.pdf /tmp/leaks/BNT CMC Peer Reviewer Comparability.pptx /tmp/leaks/20201126_BNT162b2_EMAmeeting_final.pptx /tmp/leaks/14.PNG /tmp/leaks/BWP report BioNTech mRNA COVID19 vaccine- Adopted.docx /tmp/leaks/05.PNG /tmp/leaks/2_2.png /tmp/leaks/1.png /tmp/leaks/06. Comments (Peer Review) /tmp/leaks/Annex 2 - VAL100130986 + attachment_All approved.pdf /tmp/leaks/2020 11 30 - Priority OCs to company.pdf /tmp/leaks/13.PNG /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - CHMP Overview and LoQ.docx /tmp/leaks/COVID-19 vaccine (recombinant, adjuvanted) Draft joint report as agreed by Rapps.docx /tmp/leaks/1_2.png /tmp/leaks/Summary of the ETF meeting on COVID-19 vaccine - 26 November 2020.docx
I haven't looked at anything in detail but emails are screen captures (PNG files).
The main zip contains 7z files and the password. I would recommend exploring using a VM only but seems legit from what I can tell. You'll need 7zip to extract because it uses AES encryption.
/tmp/leaks/EMA LEAKS.7z /tmp/leaks/Leaked Files from EMA.7z /tmp/leaks/password.txt
Exploded contents for the above:
/tmp/leaks/Priority OCs in quality LoQ - COVID-19 mRNA Vaccine BioNTech.docx /tmp/leaks/EudraLink - H0005735_ Transfer Plan 11.11.2020 /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - CHMP Opinion.docx /tmp/leaks/11.PNG /tmp/leaks/09. Applicant-Rapps-EMA CMC TC - 26.11.2020 /tmp/leaks/12.PNG /tmp/leaks/Rapporteur's Rolling Review Report New Active Substance Status - COVID-19 mRNA Vaccine BioNTec.doc /tmp/leaks/01.png /tmp/leaks/Written procedure for COVID-19_mRNA_Vaccine_BioNTech-5735 – for your comments by 30_11 17_00 CET.msg /tmp/leaks/07.PNG /tmp/leaks/p3.jpg /tmp/leaks/03.PNG /tmp/leaks/Rapporteur Rolling Review Report Overview LoQ - COVID-19 mRNA Vaccine BioNTech.docx /tmp/leaks/Agenda for ETF meeting on COVID-19 vaccines - 26 November 2020.docx /tmp/leaks/10.PNG /tmp/leaks/08.PNG /tmp/leaks/MLT rolling report on COVID-19 discussions.docx /tmp/leaks/Eudralink to company - 30.11.2020 /tmp/leaks/2020 11 20 ARs to applicant /tmp/leaks/2_1.png /tmp/leaks/M3 20 Nov 2020 FDA Query Responses.pdf /tmp/leaks/Rapporteur's Rolling Review Report Quality - COVID-19 mRNA Vaccine BioNTec.doc /tmp/leaks/INX100434736_AnalyticalMethodTransferBNT162b2-DPMethods.pdf /tmp/leaks/04.PNG /tmp/leaks/Annex 3 - BNT162b2 Manufacturing Equipment and Scale.pdf /tmp/leaks/p2.jpg /tmp/leaks/3.png /tmp/leaks/BNT162b2 EMA-Rapp CMC Meeting 26-Nov-2020 /tmp/leaks/06.PNG /tmp/leaks/1_3.png /tmp/leaks/02. Rapporteur's (SE) AR /tmp/leaks/09.PNG /tmp/leaks/2.png /tmp/leaks/02.PNG /tmp/leaks/Peer Reviewers Comments_NO 23.11.2020.docx /tmp/leaks/1_1.png /tmp/leaks/p1.jpg /tmp/leaks/Annex 1 - Draft 3.2.P.2.2 Drug Product.pdf /tmp/leaks/post-meeting note priority of OCs /tmp/leaks/COVID-19 mRNA Vaccine BioNTech - EMA peer review comments.docx /tmp/leaks/2020-11-26 ETF (vaccines) /tmp/leaks/M1 20 Nov 2020 FDA Query Responses.pdf /tmp/leaks/COVID-ETF recommendation on the start of rolling review for Ad26 COV2 S revSR /tmp/leaks/10. Interim Opinion - 30.11.2020 /tmp/leaks/p4.jpg /tmp/leaks/Annex 4 - BNT162b2 CMC Data Timelines_for Pre-sub Meeting_PPQ.pdf /tmp/leaks/BNT CMC Peer Reviewer Comparability.pptx /tmp/leaks/20201126_BNT162b2_EMAmeeting_final.pptx /tmp/leaks/14.PNG /tmp/leaks/BWP report BioNTech mRNA COVID19 vaccine- Adopted.docx /tmp/leaks/05.PNG>